13 min

BIO leadership shakeup followed clashes with board POLITICO's Pulse Check

    • News

The leading industry group for biopharmaceutical companies is reeling after the departure of its CEO — just as the Biden administration is poised to begin implementing a new law aimed at reducing drug prices and as the balance of power could shift in Congress. Megan Wilson talks with Katherine Ellen Foley about the turmoil at the industry group. Plus, Chris Hammond, a Covid long-hauler, shares what life has been like for him, the Johns Hopkins trials he's a part of, and why he's not optimistic about additional Covid funding from Congress.

The leading industry group for biopharmaceutical companies is reeling after the departure of its CEO — just as the Biden administration is poised to begin implementing a new law aimed at reducing drug prices and as the balance of power could shift in Congress. Megan Wilson talks with Katherine Ellen Foley about the turmoil at the industry group. Plus, Chris Hammond, a Covid long-hauler, shares what life has been like for him, the Johns Hopkins trials he's a part of, and why he's not optimistic about additional Covid funding from Congress.

13 min

Top Podcasts In News

Rachel Maddow, MSNBC
NPR
The New York Times
Serial Productions & The New York Times
The Daily Wire
New York Magazine

More by POLITICO

POLITICO
POLITICO
POLITICO
POLITICO
POLITICO
POLITICO